Skip navigation
Skip navigation

Can long term therapy with oral nucleos(t)ide analogs influence the prognosis of chronic hepatitis B-related complications?

dc.contributor.authorOoi, Marie
dc.contributor.authorTeoh, Narcissus
dc.date.accessioned2015-12-10T22:16:44Z
dc.identifier.issn0815-9319
dc.identifier.urihttp://hdl.handle.net/1885/51085
dc.publisherBlackwell Publishing Ltd
dc.sourceJournal of Gastroenterology and Hepatology
dc.subjectKeywords: adefovir dipivoxil; alanine aminotransferase; alpha interferon; entecavir; hepatitis B surface antigen; hepatitis B(e) antigen; lamivudine; nucleoside derivative; nucleotide derivative; peginterferon alpha2a; telbivudine; tenofovir; virus DNA; age; antivi
dc.titleCan long term therapy with oral nucleos(t)ide analogs influence the prognosis of chronic hepatitis B-related complications?
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume27
dc.date.issued2012
local.identifier.absfor110307 - Gastroenterology and Hepatology
local.identifier.ariespublicationu4971216xPUB216
local.type.statusPublished Version
local.contributor.affiliationOoi, Marie, The Canberra Hospital
local.contributor.affiliationTeoh, Narcissus, College of Medicine, Biology and Environment, ANU
local.description.embargo2037-12-31
local.bibliographicCitation.issue10
local.bibliographicCitation.startpage1541
local.bibliographicCitation.lastpage1543
local.identifier.doi10.1111/j.1440-1746.2012.07221.x
dc.date.updated2016-02-24T11:31:40Z
local.identifier.scopusID2-s2.0-84866564194
local.identifier.thomsonID000309070000001
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Ooi_Can_long_term_therapy_with_2012.pdf107.71 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator